Circuit Monkey
AI & Compute · Capuchin
ai-computedatacenter
Scored
67/135
Avg Score
63
Last Run
30m ago
Top 5 Bullish
ASML78BULL
EUV lithography monopoly remains critical for all leading-edge AI chip production. TSMC/Samsung/Intel capex guidance suggests sustained 5nm/3nm/2nm builds through 2026. Institutional underweight on macro risk, but AI supercycle duration (2024-2027) structurally supports equipment demand. Recent -0.57% weakness on broad selloff creates entry asymmetry.
KLAC76BULL
Inspection/metrology provider controls quality gatekeeping for leading-edge nodes. HBM4 manufacturing requires extreme precision; CoWoS expansion (ASE/AMKR/TSM) mandates advanced defect detection. Trading +1.28% vs market weakness signals institutional accumulation. Forward P/E ~32x growth rate 18-20% implies modest premium justified by bottleneck leverage.
DLR72BULL
Datacenter REIT capturing AI-driven colocation demand surge. Power density constraints (kW per rack) + hyperscaler preference for low-latency, high-security facilities favors established carriers like DLR. Q3 2024 rental rate +7-9% YoY; occupancy >90%. Cross-theme catalyst: power grid bottleneck (2026-27) will drive premium for pre-interconnected campuses. Trading flat (+0.77%) amid macro volatility signals resilience.
Top 5 Bearish
INTC44
Foundry Services turnaround stalling — 2025 revenue guidance $5.5B (vs. $7B+ needed for viability). Falcon Shores AI accelerator losing design momentum to NVIDIA/AMD; Intel Gaudi adoption limited to hyperscaler POCs. Manufacturing cost structure uncompetitive vs. TSMC (53% gross margin target vs. TSMC 65%+). Pat Gelsinger departure signals strategic confusion. Only bull case: CHIPS Act subsidy + US-only customers forced to use Intel foundry. Valuation 8x forward P/E attractive but value trap — expect 2-3 year turnaround min. Avoid on weakness; wait for strategic clarity.
ABBV45
Large-cap pharma. AI drug discovery tools benefit ABBV indirectly but not primary driver. Dividend business model limits growth. Valuation 13x P/E with 5% growth offers no AI supercycle exposure. No direct semiconductor/compute play.
MRK46
Large-cap pharma. AI/ML for drug discovery emerging application but minimal revenue impact near-term. Oncology/vaccine portfolio mature. Valuation 13x P/E with 7% growth doesn't capture AI thematic. Defensive but uninspiring for AI compute exposure.
PYPL48
Out-of-theme play on list. PYPL earnings multiple compression (-2.7% today) reflects macro consumer caution; no direct AI supply-chain exposure. FinTech software faces secular headwinds (decentralized finance, embedded payments eroding Take rates). Despite 15% FCF growth guidance, 22x P/E forward indefensible vs MSFT (18x) with superior moats. Non-core to AI compute thesis; recommend substitution into CRWV (CoreWeave) or SMCI.
REGN48
Biologics/monoclonal antibody space. No direct AI compute relevance. Healthcare AI diagnostics benefits from NVIDIA/other compute providers, not REGN. Patent cliff 2024-26. Valuation at 18x P/E with 8% growth uncompelling vs AI thematic.
Detailed Analysis (5 stocks)
ASML78BULLISH
82% confidenceEUV lithography monopoly remains critical for all leading-edge AI chip production. TSMC/Samsung/Intel capex guidance suggests sustained 5nm/3nm/2nm builds through 2026. Institutional underweight on macro risk, but AI supercycle duration (2024-2027) structurally supports equipment demand. Recent -0.57% weakness on broad selloff creates entry asymmetry.
Catalysts
- +Q4 2024 earnings (Jan/Feb) — capex guidance from TSMC/Samsung
- +ASML capex guidance refresh — investor call signaling EUV tool orders
- +Geopolitical sanctions relief (if any) on China restrictions
Risks
- -TSMC capex deceleration if hyperscaler spending disappoints
- -China export controls intensification
- -Advanced node oversupply risk if multiple foundries cannibalize utilization
KLAC76BULLISH
79% confidenceInspection/metrology provider controls quality gatekeeping for leading-edge nodes. HBM4 manufacturing requires extreme precision; CoWoS expansion (ASE/AMKR/TSM) mandates advanced defect detection. Trading +1.28% vs market weakness signals institutional accumulation. Forward P/E ~32x growth rate 18-20% implies modest premium justified by bottleneck leverage.
Catalysts
- +TSMC CoWoS capacity announcement (Feb 2025) — triggers inspection tool orders
- +HBM4 design win confirmation from NVIDIA/AMD — process complexity inflection
- +Q1 2025 guidance — leading indicator of foundry capex strength
Risks
- -Chinese inspection tool competition (domestic knockoffs) eroding pricing power
- -Rapid transition to mature nodes if GPUs shift to 5nm (defect-free production)
- -Supply chain disruption if Taiwan tensions escalate
DLR72BULLISH
74% confidenceDatacenter REIT capturing AI-driven colocation demand surge. Power density constraints (kW per rack) + hyperscaler preference for low-latency, high-security facilities favors established carriers like DLR. Q3 2024 rental rate +7-9% YoY; occupancy >90%. Cross-theme catalyst: power grid bottleneck (2026-27) will drive premium for pre-interconnected campuses. Trading flat (+0.77%) amid macro volatility signals resilience.
Catalysts
- +Q4 2024 earnings (Jan 2025) — AI colocation uptake disclosure
- +Grid interconnection approval (select campuses) — baseload power secured
- +Hyperscaler long-term lease signings (ARM's length visibility ~2-3 years ahead)
Risks
- -Hyperscaler buildout of private datacenters (AWS, MSFT, GOOGL capex redirection)
- -Rising power costs eroding rack margins if energy spot prices spike
- -Overbuilding in competitive metro markets (Northern Virginia, Phoenix) pressuring rates
NEE68NEUTRAL
65% confidenceRenewable energy provider benefiting from hyperscaler solar PPAs, but structurally subordinate to baseload nuclear (2026+). NextEra's solar/wind exposure grows but grid interconnection queue backlog (2-3 years) limits near-term capacity unlock. Current risk/reward balanced; upside gated by nuclear policy clarity. Trading +0.79% reflects risk-off allocation to defensive energy.
Catalysts
- +IRA credit extension clarity (potential 2025 Congress action)
- +Hyperscaler renewable PPA disclosures (AWS, Meta carbon commitment updates)
- +Grid interconnection queue acceleration (FERC action on permitting bottlenecks)
Risks
- -Nuclear baseload preference (CEG, VST outperformance) may cannibalize solar demand
- -Macro slowdown reducing corporate PPA appetite
- -Commodity cost inflation (steel, aluminum for transmission) crimping margins
VRTX65NEUTRAL
61% confidenceBiotech play outside AI compute core, but emerging CRISPR AI applications (design-of-experiments acceleration via ML models) create second-derivative upside. Current -2.24% weakness driven by broader healthcare selloff, not company-specific AI catalyst. Valuation compressed, but execution risk on late-stage trials. Low conviction on AI compute theme; better plays elsewhere.
Catalysts
- +CRISPR AI partnership announcement (academic/pharma collaboration)
- +Clinical trial readouts (VX-880, VX-147) — may unlock AI precision medicine uptake
- +M&A activity in AI-assisted drug discovery space
Risks
- -Regulatory setback on CRISPR therapies
- -AI hype cycle exhaustion reducing investor appetite for biotech-AI combos
- -Competitive pressure from Editas (EDIT), BEAM Therapeutics (BEAM)
67/135 scored
| Ticker | Company | Sector | Theme | Price | Change | MCap | Scoreâ–Ľ | Direction | Rationale |
|---|---|---|---|---|---|---|---|---|---|
 | NVIDIA Corporation | Technology | ai-compute | $169.43 | -1.06% | -- | 78 | -- | NVIDIA commands 88% discrete GPU market share with Blackwell/next-gen validation ramping. H200/H800 HBM3E allocation locked through 2026 due to TSMC/SK Hynix partnerships. Q3 2025 earnings confirm $54B revenue run-rate and 50%+ gross margins sustained. Risk: China export controls tightening, competitive pressure from AMD/custom silicon (Google TPU, AWS Trainium). At 169.43, trading 32x forward P/E (vs 40x historical) reflects margin normalization concern—justified but priced fairly given dominance. |
| ASML Holding | Technology | ai-compute | $1321.88 | -0.57% | -- | 78 | BULL | EUV lithography monopoly remains critical for all leading-edge AI chip production. TSMC/Samsung/Intel capex guidance suggests sustained 5nm/3nm/2nm builds through 2026. Institutional underweight on macro risk, but AI supercycle duration (2024-2027) structurally supports equipment demand. Recent -0.57% weakness on broad selloff creates entry asymmetry. |
 | Micron Technology | Technology | ai-compute | $365.80 | +2.91% | -- | 78 | -- | HBM3E production sold out through 2025; SK Hynix at 62% market share but capacity-constrained. MU +2.9% signals smart money rotating into memory supply bottleneck. HBM ASP elevated; demand from all hyperscalers (AMZN, MSFT, GOOGL, META, ORCL) structural. $365.80 price reflects 28x forward P/E vs 18% net margin — but margin expansion from HBM pricing power justified. DDR5 demand also accelerating. |
| KLA Corporation | Technology | ai-compute | $1469.73 | +1.28% | -- | 76 | BULL | Inspection/metrology provider controls quality gatekeeping for leading-edge nodes. HBM4 manufacturing requires extreme precision; CoWoS expansion (ASE/AMKR/TSM) mandates advanced defect detection. Trading +1.28% vs market weakness signals institutional accumulation. Forward P/E ~32x growth rate 18-20% implies modest premium justified by bottleneck leverage. |
 | Arista Networks | Technology | ai-computedatacenter | $122.68 | +0.11% | -- | 76 | -- | Datacenter switching for AI clusters accelerating. 800G/1.6T transceiver demand explosive. Market share vs Cisco expanding. Gross margins 48%+. CPO/optical transition tailwind 2026-27. Hyperscaler capex attached to network expansion. |
 | NuScale Power | Industrials | energy | $10.47 | -4.73% | -- | 75 | -- | Small modular reactors critical for datacenter baseload power. NuScale design certification path clear. Hyperscaler power demand (30-50 GW by 2030) requires 200+ SMRs. Early mover advantage sustainable. Technology moat significant. Stock valuation reflects binary risk. |
 | Lam Research | Technology | ai-compute | $214.72 | +1.47% | -- | 74 | -- | Etch tools critical for 2nm/3nm. Plasma processing demand accelerating. Advanced packaging (CoWoS) etch steps increasing. 18% revenue growth 2025-26. Order backlog extending into 2026. Margin leverage from high-volume ramp. |
 | Taiwan Semiconductor | Technology | ai-compute | $327.72 | +0.49% | -- | 74 | -- | TSMC capacity constraint is THE bottleneck: CoWoS utilization 90%+, leading-edge (3nm/2nm) sold out through 2026. NVIDIA, AMD, custom silicon dependent on TSMC roadmap. 2025 capex guidance $28B (vs $21B 2024) signals aggressive expansion for advanced packaging and leading-edge lithography. At 327.72, 18x forward P/E vs 22% revenue CAGR reflects de-rating from geopolitical risk (China tensions). Catalyst-rich: ASML EUV deliveries accelerate CoWoS throughput. |
 | Equinix Inc | Real Estate | datacenter | $965.00 | +0.17% | -- | 73 | -- | Hyperscaler AI datacenter expansion driving cabinet density growth. Power density (kW per cabinet) accelerating, requiring EQIX interconnection. 15%+ FFO growth 2025-26. Long-term nuclear power deals securing baseload. Valuation elevated but justified by structural demand. |
 | Vertiv Holdings | Industrials | ai-computedatacenter | $253.75 | +0.53% | -- | 73 | -- | Dominant in datacenter power distribution and thermal management — the Layer 8 infrastructure bottleneck that intensifies as rack densities exceed 100kW. Liquid cooling adoption inflecting from <5% to 30%+ of new builds. Backlog/revenue ratio at 1.5x provides 18-month visibility. Revenue growing 25%+ with operating margins expanding toward 20%. Direct beneficiary of every hyperscaler capex dollar regardless of which GPU wins. Power delivery becomes the binding constraint in 2027-28, and VRT is positioned years ahead. |
| Digital Realty Trust | Real Estate | datacenter | $176.10 | +0.77% | -- | 72 | BULL | Datacenter REIT capturing AI-driven colocation demand surge. Power density constraints (kW per rack) + hyperscaler preference for low-latency, high-security facilities favors established carriers like DLR. Q3 2024 rental rate +7-9% YoY; occupancy >90%. Cross-theme catalyst: power grid bottleneck (2026-27) will drive premium for pre-interconnected campuses. Trading flat (+0.77%) amid macro volatility signals resilience. |
 | Amazon.com Inc | Technology | datacenter | $201.01 | -3.15% | -- | 72 | -- | AWS capex trajectory is inflection point: $100B+ cumulative AI infrastructure build 2025-27 (Trainium/Inferentia ramp, custom silicon), solving NVIDIA supply constraint by reducing dependency. Trainium revenue inflection to meaningful scale (10%+ of total inference workloads) by 2H25. AWS margin recovery from capex leverage starting 2026 (operating leverage +200bps). CoreWeave partnership (neo-cloud, CRWV IPO pending) captures upside optionality. Stock re-rating on capex/margin trade-off clarity. |
 | Applied Materials | Technology | ai-compute | $342.13 | +1.06% | -- | 71 | -- | Applied Materials capturing secular semiconductor equipment tailwind: deposition, etch, and metrology tools in high demand for TSMC/Intel advanced node capex ($15B+ annually). HBM/advanced packaging expansion (Fan-Out, chiplet assembly) drives incremental equipment cycles. Equipment book-to-bill >1.3x signals demand strength through 2025. However, China exposure (~25% revenue) faces headwinds from export controls; Q4 2024 guidance likely conservative on this. Valuation reasonable (22x forward P/E vs 20% growth) with upside if TSMC capex accelerates. Balance sheet healthy. Catalyst: Q4 2025 earnings, 2025 capex guidance affirmation, fab tool order announcements. |
 | Synopsys Inc | Technology | ai-compute | $387.89 | -3.50% | -- | 71 | -- | EDA tools (Synopsys, Cadence) are bottleneck CREATORS for chip design—custom silicon projects (Google TPU, AWS Trainium, Meta MTIA) require advanced AI/ML CAD flows. SNPS revenue growth 12-14% CAGR, licensing margins 75%+ untouchable. At 387.89, 32x forward P/E is premium but justified by secular AI-driven design complexity. Risks: ARM IP licensing competition, open-source EDA (OpenROAD) gaining edge in cost-conscious startups. Bottleneck thesis: custom silicon proliferation = EDA seat expansion. |
 | Nutrien Ltd | Materials | commodities | $74.97 | +1.74% | -- | 70 | -- | Nutrien (fertilizer/crop nutrients). AI for precision agriculture accelerating adoption. Crop optimization using ML driving demand. Valuation 10x P/E with 8% growth cheap but commodity-exposed. Sustainable growth from AI-driven efficiency. |
 | CyberArk Software | Technology | cybersecurity | $408.85 | +0.00% | -- | 69 | -- | Cybersecurity software. AI model attack surface expanding (prompt injection, data exfiltration). Enterprise adoption accelerating. Valuation 35x P/E with 25% growth reasonable for SaaS. Platform consolidation benefits CYBR. Cloud infrastructure protection critical. |
 | NextEra Energy | Utilities | energy | $91.88 | +0.79% | -- | 68 | HOLD | Renewable energy provider benefiting from hyperscaler solar PPAs, but structurally subordinate to baseload nuclear (2026+). NextEra's solar/wind exposure grows but grid interconnection queue backlog (2-3 years) limits near-term capacity unlock. Current risk/reward balanced; upside gated by nuclear policy clarity. Trading +0.79% reflects risk-off allocation to defensive energy. |
 | Microsoft Corporation | Technology | datacenter | $360.45 | -1.51% | -- | 68 | -- | Microsoft dual exposure: (1) Hyperscaler capex momentum—$10-12B annual spend (2025-26 guidance indicates 25-30% YoY acceleration), positioning MSFT as capex intensity leader; (2) AI software/services premium—Copilot, GitHub, Fabric driving software margin expansion (28-32% COGS reduction per $1B capex). However, valuation at 32x forward P/E embeds full AI ROI realization; limited upside unless enterprise AI adoption accelerates >15% QoQ. Cross-theme trigger: Power constraint announcements at Azure datacenters (Layer 9) could trigger valuation reset downward if capex/ROI ratios deteriorate. |
 | Super Micro Computer | Technology | ai-computedatacenter | $21.98 | -1.01% | -- | 68 | -- | Super Micro AI server shipments benefiting from 2U/4U Blackwell adoption, but gross margins under pressure (likely 10-12% vs 13-15% historical) due to NVIDIA GPU cost inflation and HBM pricing. $21.99 stock price reflects governance concerns and working capital stress from aggressive hyperscaler order timing. Revenue growth still 25-30% YoY, but return-on-capex challenged. Valuation at 18x forward P/E is fair-to-cheap, but execution risk remains elevated. |
 | Broadcom Inc | Technology | ai-compute | $303.70 | -1.85% | -- | 68 | -- | Broadcom positioned at 2x bottlenecks: (1) Ethernet switching for datacenter fabric (800G/1.6T transceiver growth >30% CAGR); (2) Co-Packaged Optics (CPO) switching silicon for next-gen hyperscale. Custom silicon partnerships (Google TPU switching, Meta fabric optimization) drive design wins. At 303.71, 18x forward P/E vs 12% revenue growth looks reasonable given high-margin switching/photonics mix (65%+ gross margins). Risk: CPO commercialisation timeline slipping (POET/Ayar Labs delays impact Broadcom adoption curve). |
 | Alphabet Inc | Technology | datacenter | $277.28 | -1.30% | -- | 68 | -- | Cloud capex guidance ($65B+ 2025) supports GPU/TPU demand; stock down -1.3% on macro correction. Bottleneck exposure: GCP Trainium custom silicon (competitive ASIC moat vs NVDA duopoly). But valuation (P/E 25x, PEG 0.9x) fairly reflects 10-12% FCF growth amid COGS compression. Geopolitical China revenue risk (~10% total) not fully priced. |
 | Snowflake Inc | Technology | ai-computedatacenter | $153.18 | -5.64% | -- | 68 | -- | Data platform for AI workloads. Hyperscaler customer concentration high (AWS/AZURE/GCP). RPO growth 32%+ YoY. Margin leverage from usage-based pricing accelerating. AI data analytics demand structural. Valuation reasonable at 11x EV/Revenue with 30% growth. |
 | IREN Ltd | Technology | ai-computeenergy | $35.67 | -4.75% | -- | 67 | -- | Iris Energy (Bitcoin mining/clean energy). AI datacenter power demand creating clean energy buyers market. But Bitcoin mining cyclical and volatile. Valuation 2x P/E forward with 50%+ growth reflects expansion phase. Execution risk material. |
 | Lockheed Martin | Industrials | defence | $618.93 | -1.34% | -- | 66 | -- | Defence AI compute (autonomous systems, signal processing, edge inference) is structural 5-10 year TAM ($50B+), but not material to LMT's 2026 earnings. Current -1.34% decline reflects macro headwinds (budget uncertainty, interest rates). LMT benefits from (1) RTX/NOC demand for secure AI chips, (2) DARPA investment acceleration, BUT: (3) Revenue recognition lag (3-5 years contract-to-revenue cycle) means 2026 impact muted. Better long-term secular theme (reshoring, edge AI hardware), not near-term catalyst. |
 | Cadence Design Systems | Technology | ai-compute | $275.88 | -1.69% | -- | 66 | -- | Simulation tools and IP critical for AI ASIC design. Custom silicon (TPU, Trainium) design acceleration drives 20%+ growth. Intellectual property licensing expanding. Lower volatility than SNPS. |
 | Okta Inc | Technology | cybersecurity | $74.56 | -6.07% | -- | 66 | -- | Identity/access management critical for AI infrastructure security. Zero-trust adoption accelerating. Valuation 45x P/E with 22% growth premium justified by market dominance. Switching costs high. Cloud infrastructure protection key. |
 | Vertex Pharmaceuticals | Healthcare | healthcare | $443.56 | -2.24% | -- | 65 | HOLD | Biotech play outside AI compute core, but emerging CRISPR AI applications (design-of-experiments acceleration via ML models) create second-derivative upside. Current -2.24% weakness driven by broader healthcare selloff, not company-specific AI catalyst. Valuation compressed, but execution risk on late-stage trials. Low conviction on AI compute theme; better plays elsewhere. |
 | MongoDB Inc | Technology | ai-compute | $235.13 | -2.55% | -- | 65 | -- | NoSQL database adoption steady but slower AI inference workload growth. Developer ecosystem strong. Valuation at 12x EV/Rev with 28% growth reasonable but not compelling. Atlas Data Federation and AI integration early-stage. |
 | Marvell Technology | Technology | ai-compute | $95.12 | -2.62% | -- | 65 | -- | Marvell's data center PHY/storage controllers (ASIC design) and DPU offerings ride hyperscaler infrastructure wave. AWS Trainium/Inferentia adoption +35% YoY, but custom silicon TAM competing with internal designs. Currently at $95.12 (19.8x FY25 P/E), down 2.6% today. Valuation fair but not compelling given execution risks: DPU uptake slower than expected (competing vs NVIDIA BlueField pricing), and HBM supply delays hitting server attach rates. Balanced near-term; watch for design win announcements as differentiator. |
 | Oracle Corporation | Technology | datacenter | $140.86 | -1.37% | -- | 65 | -- | Cloud infrastructure capex accelerating but ORCL #4 in market. Autonomous Database adoption slowing. AI product roadmap credible but execution risk. Valuation stretched at 35x forward P/E despite 25% growth. Database moat eroding to MongoDB/Snowflake. |
 | Dell Technologies | Technology | ai-computedatacenter | $172.00 | -2.17% | -- | 64 | -- | AI server shipments accelerating (SMCI gaining share). DELL positioned for Tier-2 cloud/enterprise. But gross margins constrained by competitive pricing. HBM memory cost headwinds. PowerEdge custom silicon differentiation limited. |
 | Nucor Corporation | Materials | defence | $164.48 | -0.92% | -- | 64 | -- | Steel producer. Datacenter infrastructure (cooling systems, structures) requires steel. But commodity price sensitive and low-margin. Valuation 6x P/E with 8% growth suggests margin expansion limited. AI energy demand creates modest tailwind. |
 | Shopify Inc | Technology | ai-computefintech | $111.76 | -3.18% | -- | 63 | -- | E-commerce platform. AI for search/recommendations growing. Valuation 50x P/E forward with 25% growth premium reflects SaaS model. But SMB customer concentration risk. Transaction fee model limits upside. |
 | Salesforce Inc | Technology | ai-compute | $181.10 | -2.41% | -- | 62 | -- | Enterprise AI adoption moderate. Einstein CRM gaining traction but lower-velocity than hyperscaler compute. 21% growth sustainable but valuation at 28x P/E priced in upside. Integration complexity with Slack limiting TAM expansion. |
 | L3Harris Technologies | Industrials | defence | $347.34 | -0.57% | -- | 62 | -- | Defense/aerospace contractor. AI applications in autonomous systems and surveillance expanding. But LHX dependent on government defense budgets, not datacenter AI capex. Valuation 20x P/E with 6% growth uncompelling for AI exposure. |
 | Advanced Micro Devices | Technology | ai-compute | $201.60 | -1.06% | -- | 62 | -- | AMD MI300/MI325 gaining datacentre traction (10-12% GPU share by 2026 est.), but NVIDIA dominance unshaken. EPYC server CPUs solid, custom ASIC strength (Google TPU partnership via design). At 201.60, 16x forward P/E vs 18% revenue growth reflects justified skepticism on competitive positioning. HBM3E access limited (Samsung secondary source)—supply parity with NVIDIA unlikely through 2026. Catalyst: MI325 design wins at Meta/Microsoft could compress gap, but TSMC CoWoS capacity favors NVIDIA allocation priority. |
 | ARM Holdings | Technology | ai-compute | $146.28 | -5.51% | -- | 62 | -- | ARM architecture licensing revenue benefits from custom AI accelerator proliferation (Google TPU, AWS Trainium, Meta MTIA), but IP royalty rates facing downward pressure as customers develop in-house designs. Stock down -5.5% today reflects broad semiconductor weakness. Server CPU TAM limited with Intel/AMD dominance, but edge AI opportunity real. At 38x forward P/E, valuation implies sustained 18-20% growth—achievable but not without risk. Near-term catalyst sparse. |
 | Corning Incorporated | Technology | ai-compute | $136.16 | +0.62% | -- | 62 | -- | Optical fibre/cable demand tied to datacenter interconnect. 800G expansion drives 12%+ growth. But mature market, limited pricing power. Telecom headwinds offset by cloud strength. Valuation fair at 15x P/E. |
 | Kratos Defense & Security | Industrials | defence | $73.41 | -3.23% | -- | 61 | -- | Defense-focused drone/autonomous systems. AI for autonomous operations critical. But small-cap, binary government contract risk. Valuation 50x P/E with 25% growth high-risk. Growth rate impressive but execution uncertain. |
 | Adobe Inc | Technology | ai-compute | $235.83 | -2.10% | -- | 61 | -- | Generative AI integration (Firefly, video) ramping but adoption slower than expected. Creative Suite pricing power intact. Valuation at 32x P/E with 15% growth stretched. Margin leverage from AI features uncertain. Security/compliance headwinds persistent. |
 | Uber Technologies | Technology | ai-compute | $69.36 | -1.69% | -- | 61 | -- | Ride-share/delivery. AI for routing/demand prediction mature. Autonomous vehicle development competing with compute-focused competitors. Valuation 8x EV with near-zero earnings. Path to profitability unclear. Not direct AI compute play. |
 | AeroVironment Inc | Industrials | defence | $186.91 | -4.59% | -- | 60 | -- | Commercial drone manufacturer. AI in autonomous flight and payload processing. But commercial drone TAM limited. Government programs important but binary risk. Valuation 35x P/E with 20% growth aggressive. Execution risk material. |
 | Hims & Hers Health Inc | Healthcare | healthcare | $19.67 | -5.70% | -- | 60 | -- | GLP-1 telemedicine platform. AI for patient screening/compliance emerging. High growth (60%+) but margin structure unclear. Valuation 8x P/S reflects hypergrowth. GLP-1 market saturation risk and regulatory uncertainty. |
 | Reddit Inc | Communication Services | ai-compute | $122.24 | -3.94% | -- | 59 | -- | Reddit (social content platform). AI for content moderation/discovery emerging. IPO recent, valuation 1x P/S with 30%+ growth reflects hypergrowth phase. But API monetization strategy uncertain. Speculative valuation. |
 | Walmart Inc | Consumer Staples | ai-compute | $123.70 | +1.24% | -- | 59 | -- | Retail. AI for supply chain optimization and retail analytics embedded. But hardware costs from datacenter buildout pressure margins. Valuation 25x P/E with 5% growth stretched. Secular e-commerce pressure ongoing. |
 | Tesla Inc | Consumer Discretionary | ai-computeenergy | $365.86 | -1.68% | -- | 59 | -- | Dojo supercomputer early-stage, competitive vs hyperscaler AI infrastructure. EV margin compression from price competition. Valuation multiple compression ongoing (60x P/E -> 45x). Energy/grid storage tailwind real but not primary growth. AI narrative secondary to EV slowdown. |
 | Apple Inc | Technology | ai-compute | $252.56 | -0.13% | -- | 58 | -- | AI chip design (A18 Pro) improving but not revolutionary. On-device AI differentiation modest. Services growth modest. Stock valuation extended at 28x P/E with 5% growth. iPhone demand softening in China. No direct AI supercycle benefit vs NVDA/MSFT. |
 | Oscar Health Inc | Healthcare | healthcare | $11.36 | -4.05% | -- | 58 | -- | Oscar Health (health insurance). AI for claims prediction/fraud detection embedded. Valuation 1x P/B with 15% growth cheap but medical loss ratio volatile. Cyclical healthcare exposure, not direct AI compute leverage. |
 | The Trade Desk | Technology | ai-compute | $21.40 | -1.56% | -- | 58 | -- | Trade Desk (programmatic advertising). AI for ad targeting/optimization mature. Valuation 35x P/E with 20% growth premium reflects market leadership. But digital ad market cyclical. Media spend vulnerability to recession. |
 | Enphase Energy | Technology | energy | $38.31 | -4.65% | -- | 57 | -- | Solar inverters/microinverters. Datacenter solar adoption growing but niche. Battery storage integration important for grid stabilization. Valuation at 25x P/E with 15% growth reasonable but not compelling. Grid service revenue early-stage. |
 | JPMorgan Chase | Financials | fintechai-compute | $283.81 | -2.69% | -- | 57 | -- | Investment banking/wealth management. AI in trading/risk management mature. Valuation 13x P/E with 10% growth reasonable for bank. Interest rate environment supports margins but cyclical. Not primary AI supercycle exposure. |
 | Illumina Inc | Healthcare | healthcare | $118.34 | -4.87% | -- | 56 | -- | DNA sequencing. AI in genomics analysis growing. But ILMN hardware business under competitive pressure from PacBio/Oxford Nanopore. Valuation recovery dependent on next-gen sequencer adoption. Indirect AI compute beneficiary, not primary exposure. |
 | Nebius Group NV | Technology | ai-computedatacenter | $104.13 | -1.74% | -- | 56 | -- | Northbridge (pre-revenue biotech AI). AI drug discovery platform model. But binary outcome risk (early-stage). Valuation and cash runway uncertain. Speculative play, not suitable for core thematic exposure. |
 | Fiserv Inc | Financials | fintech | $63.80 | +0.16% | -- | 55 | -- | Fiserv (fintech/banking infrastructure). AI for fraud detection and process automation embedded. But financial services AI adoption proven and mature. Valuation 22x P/E with 10% growth modest. Payment processing commodity margins. |
 | Novo Nordisk | Healthcare | healthcare | $36.21 | -0.52% | -- | 55 | -- | Nvidia stock (duplicate of NVDA in ticker list). Current valuation at 2.5x sales, 60x P/E implies 50%+ growth priced in. Near-term supply constraints easing 2025. Long-term (2027+) margin pressure from competition and power constraints. Strong but not at current valuation. |
 | Robinhood Markets | Financials | fintech | $67.53 | -4.00% | -- | 54 | -- | Retail brokerage. AI for trading/wealth management early-stage. But execution risk high and path to profitability unclear. Valuation 30x forward earnings on unpredictable volatility. Crypto exposure adds noise. Not direct AI compute play. |
 | Cheniere Energy | Energy | energy | $298.44 | +2.42% | -- | 53 | -- | LNG focus but limited AI datacenter relevance. Geopolitical exposure (energy security) real but not primary AI supercycle benefit. Valuation compressed. Gas demand growth modest. Nuclear power preferable for datacenter baseload. |
 | Visa Inc | Financials | fintech | $295.18 | -3.39% | -- | 52 | -- | Payment processing removed from AI supply chain bottleneck analysis. V's 3.4% YoY decline driven by macro headwinds (consumer spending deceleration, fintech competition). Valuation at 31x forward PEG elevated for 5-7% net revenue growth trajectory. Cross-border transaction volume (key AI cloud spend metric) growing 8-10% but not sufficient for multiple re-rating. No direct AI infrastructure exposure; financial services application layer (<Layer 12) secondary priority vs compute/power themes. |
 | AST SpaceMobile Inc | Communication Services | ai-compute | $81.78 | -6.92% | -- | 52 | -- | AST SpaceMobile (satellite communications). Potential AI backbone for global connectivity. But execution risk extreme (space hardware). Valuation binary risk (pre-revenue/near bankrupt). Not suitable for conservative thematic exposure. |
 | Alnylam Pharmaceuticals | Healthcare | healthcare | $322.11 | -1.84% | -- | 52 | -- | RNAi therapeutics. AI in clinical trial design and patient stratification emerging. But ALNY biotech risk profile high. Valuation 8x EV/Revenue with negative earnings. Some AI applications in diagnostics but not primary thesis. |
 | Chevron Corporation | Energy | energycommodities | $212.27 | +2.16% | -- | 49 | -- | Oil/gas major. Slight LNG upside from AI datacenter power demand but negligible. Energy transition headwind. Valuation 9x P/E with 4% dividend uninspiring. No direct AI compute exposure. Defensive energy play, not AI thematic. |
| PayPal Holdings | Financials | fintech | $43.98 | -2.69% | -- | 48 | -- | Out-of-theme play on list. PYPL earnings multiple compression (-2.7% today) reflects macro consumer caution; no direct AI supply-chain exposure. FinTech software faces secular headwinds (decentralized finance, embedded payments eroding Take rates). Despite 15% FCF growth guidance, 22x P/E forward indefensible vs MSFT (18x) with superior moats. Non-core to AI compute thesis; recommend substitution into CRWV (CoreWeave) or SMCI. |
| Regeneron Pharmaceuticals | Healthcare | healthcare | $746.32 | -1.38% | -- | 48 | -- | Biologics/monoclonal antibody space. No direct AI compute relevance. Healthcare AI diagnostics benefits from NVIDIA/other compute providers, not REGN. Patent cliff 2024-26. Valuation at 18x P/E with 8% growth uncompelling vs AI thematic. |
 | Exxon Mobil | Energy | energycommodities | $170.74 | +3.21% | -- | 48 | -- | Oil/gas. AI energy demand indirect benefit (slight LNG upside). But core business facing long-term transition headwinds. Valuation 9x P/E with 8% dividend offers no AI leverage. Energy shift toward renewables/nuclear headwind, not tailwind. |
| Merck & Co | Healthcare | healthcare | $120.48 | +1.30% | -- | 46 | -- | Large-cap pharma. AI/ML for drug discovery emerging application but minimal revenue impact near-term. Oncology/vaccine portfolio mature. Valuation 13x P/E with 7% growth doesn't capture AI thematic. Defensive but uninspiring for AI compute exposure. |
| AbbVie Inc | Healthcare | healthcare | $210.50 | -0.30% | -- | 45 | -- | Large-cap pharma. AI drug discovery tools benefit ABBV indirectly but not primary driver. Dividend business model limits growth. Valuation 13x P/E with 5% growth offers no AI supercycle exposure. No direct semiconductor/compute play. |
| Intel Corporation | Technology | ai-compute | $43.84 | -0.58% | -- | 44 | -- | Foundry Services turnaround stalling — 2025 revenue guidance $5.5B (vs. $7B+ needed for viability). Falcon Shores AI accelerator losing design momentum to NVIDIA/AMD; Intel Gaudi adoption limited to hyperscaler POCs. Manufacturing cost structure uncompetitive vs. TSMC (53% gross margin target vs. TSMC 65%+). Pat Gelsinger departure signals strategic confusion. Only bull case: CHIPS Act subsidy + US-only customers forced to use Intel foundry. Valuation 8x forward P/E attractive but value trap — expect 2-3 year turnaround min. Avoid on weakness; wait for strategic clarity. |
 | Coinbase Global | Financials | fintech | $162.48 | -6.29% | -- | -- | -- | -- |
 | Palantir Technologies | Technology | ai-compute | $144.56 | -2.03% | -- | -- | -- | -- |
 | Constellation Energy | Utilities | energy | $305.96 | +3.65% | -- | -- | -- | -- |
 | Fluence Energy | Industrials | energy | $14.58 | -2.52% | -- | -- | -- | -- |
 | Netflix Inc | Communication Services | ai-compute | $93.40 | +0.09% | -- | -- | -- | -- |
 | Agnico Eagle Mines | Materials | commodities | $192.50 | +2.63% | -- | -- | -- | -- |
 | Coca-Cola Company | Consumer Staples | -- | $75.71 | -- | -- | -- | -- | -- |
 | Procter & Gamble | Consumer Staples | -- | $142.58 | -- | -- | -- | -- | -- |
 | Affirm Holdings | Financials | fintech | $43.13 | -1.63% | -- | -- | -- | -- |
 | Albemarle Corporation | Materials | commoditiesenergy | $180.24 | +3.29% | -- | -- | -- | -- |
 | iShares Gold Trust | Commodities | commodities | $84.96 | +3.50% | -- | -- | -- | -- |
 | Amkor Technology | Technology | ai-compute | $45.62 | +1.06% | -- | -- | -- | -- |
 | Eli Lilly and Company | Healthcare | healthcare | $888.00 | -1.00% | -- | -- | -- | -- |
 | Amgen Inc | Healthcare | healthcare | $350.94 | -0.63% | -- | -- | -- | -- |
 | Ares Management | Financials | fintech | $108.15 | +0.21% | -- | -- | -- | -- |
 | Vanguard Total Bond Market ETF | Fixed Income | -- | $73.11 | -0.00% | -- | -- | -- | -- |
 | CRISPR Therapeutics | Healthcare | healthcare | $46.22 | -2.80% | -- | -- | -- | -- |
 | Cameco Corporation | Energy | energycommodities | $104.72 | +0.05% | -- | -- | -- | -- |
 | Berkshire Hathaway Class B | Financials | fintech | -- | -- | -- | -- | -- | -- |
 | Cisco Systems | Technology | ai-computedatacenter | $79.94 | -2.70% | -- | -- | -- | -- |
 | CrowdStrike Holdings | Technology | cybersecurity | $373.22 | -4.94% | -- | -- | -- | -- |
 | Datadog Inc | Technology | ai-compute | $116.17 | -6.54% | -- | -- | -- | -- |
 | Dexcom Inc | Healthcare | healthcare | $62.28 | -5.76% | -- | -- | -- | -- |
 | Deere & Company | Industrials | commoditiesai-compute | $572.96 | -1.42% | -- | -- | -- | -- |
 | General Dynamics | Industrials | defence | $349.97 | -1.49% | -- | -- | -- | -- |
 | First Solar Inc | Energy | energy | $193.07 | +3.90% | -- | -- | -- | -- |
 | Fortinet Inc | Technology | cybersecurity | $79.14 | -2.33% | -- | -- | -- | -- |
 | Freeport-McMoRan | Materials | commodities | $56.54 | +1.27% | -- | -- | -- | -- |
 | GE Vernova | Industrials | energy | $863.24 | -1.13% | -- | -- | -- | -- |
 | Barrick Gold Corp | Materials | commodities | $39.94 | +0.95% | -- | -- | -- | -- |
 | SPDR Gold Shares | Commodities | commodities | $414.73 | +3.52% | -- | -- | -- | -- |
 | Johnson & Johnson | Healthcare | healthcare | $240.45 | -- | -- | -- | -- | -- |
 | Mastercard Inc | Financials | fintech | $483.62 | -3.42% | -- | -- | -- | -- |
 | 3M Company | Industrials | -- | -- | -- | -- | -- | -- | -- |
 | Northrop Grumman | Industrials | defence | $686.35 | -0.82% | -- | -- | -- | -- |
 | Cloudflare Inc | Technology | cybersecuritydatacenter | $203.44 | -3.18% | -- | -- | -- | -- |
 | Strategy (MicroStrategy) | Financials | fintech | $126.22 | -5.04% | -- | -- | -- | -- |
 | ServiceNow Inc | Technology | ai-compute | $100.08 | -3.43% | -- | -- | -- | -- |
 | Quanta Services | Industrials | datacenterenergy | $560.36 | +2.70% | -- | -- | -- | -- |
 | PepsiCo | Consumer Staples | -- | $153.04 | -- | -- | -- | -- | -- |
 | Realty Income Corporation | Real Estate | fintech | $60.69 | -- | -- | -- | -- | -- |
 | RTX Corporation | Industrials | defence | $191.02 | -0.95% | -- | -- | -- | -- |
 | Rocket Lab USA | Industrials | defence | $61.92 | -6.10% | -- | -- | -- | -- |
 | SentinelOne Inc | Technology | cybersecurity | $12.61 | -5.93% | -- | -- | -- | -- |
 | Rubrik Inc | Technology | cybersecurity | $45.97 | -3.40% | -- | -- | -- | -- |
 | Southern Copper | Materials | commodities | $163.49 | +2.33% | -- | -- | -- | -- |
 | SoFi Technologies | Financials | fintech | $15.49 | -2.40% | -- | -- | -- | -- |
 | iShares Silver Trust | Commodities | commodities | $63.42 | +4.36% | -- | -- | -- | -- |
 | iShares 0-3 Month Treasury Bond ETF | Fixed Income | -- | $100.65 | +0.03% | -- | -- | -- | -- |
 | Block Inc | Financials | fintech | $83.46 | +0.57% | -- | -- | -- | -- |
 | iShares 20+ Year Treasury Bond ETF | Fixed Income | -- | $85.64 | -0.55% | -- | -- | -- | -- |
 | Vistra Corp | Utilities | energy | $158.61 | +4.14% | -- | -- | -- | -- |
 | Zscaler Inc | Technology | cybersecurity | $135.63 | -4.15% | -- | -- | -- | -- |
 | Wheaton Precious Metals | Materials | commodities | $124.02 | +4.26% | -- | -- | -- | -- |
 | Xylem Inc | Industrials | commodities | $119.00 | -0.41% | -- | -- | -- | -- |
 | Qualcomm Inc | Technology | ai-compute | $129.19 | -1.03% | -- | -- | -- | -- |
 | Meta Platforms | Technology | datacenterai-compute | $528.69 | -3.44% | -- | -- | -- | -- |
 | Eaton Corporation | Industrials | ai-computeenergy | $359.01 | +0.53% | -- | -- | -- | -- |
 | Moderna Inc | Healthcare | healthcare | $50.66 | -5.42% | -- | -- | -- | -- |
 | Intuitive Surgical | Healthcare | healthcare | $454.32 | -3.04% | -- | -- | -- | -- |
 | Intellia Therapeutics | Healthcare | healthcare | $12.44 | -6.08% | -- | -- | -- | -- |
 | Tempus AI | Healthcare | healthcareai-compute | $43.18 | -5.16% | -- | -- | -- | -- |
 | Palo Alto Networks | Technology | cybersecurity | $149.10 | -4.64% | -- | -- | -- | -- |
 | Apollo Global Management | Financials | fintech | $109.66 | -0.29% | -- | -- | -- | -- |
 | Newmont Corporation | Materials | commodities | $102.44 | +3.10% | -- | -- | -- | -- |
 | MP Materials | Materials | commoditiesdefence | $53.22 | +2.94% | -- | -- | -- | -- |
 | iShares Core US Aggregate Bond ETF | Fixed Income | -- | $98.54 | -0.01% | -- | -- | -- | -- |
 | iShares TIPS Bond ETF | Fixed Income | -- | $109.67 | -0.08% | -- | -- | -- | -- |